Press releases
        Month Year
      
      
      
    | Su | Mo | Tu | We | Th | Fr | Sa | 
|---|---|---|---|---|---|---|
        Month Year
      
      
      
    | Su | Mo | Tu | We | Th | Fr | Sa | 
|---|---|---|---|---|---|---|
- 
Nov 6, 2006Boston Scientific Corporation (NYSE: BSX) today presented a four-year update of its key randomized, controlled clinical trials (TAXUS II, IV, V and... 
- 
Nov 6, 2006Technology serves as second-generation platform for Company's market-leading TAXUS® paclitaxel-eluting coronary stent systemBoston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the Japanese Ministry of Health, Labor and Welfare... 
- 
Nov 3, 2006Company to acquire EndoTexBoston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the NexStent® Carotid Stent... 
- 
Nov 3, 2006Innovative Technology Makes Precision™ Spinal Cord Stimulator Accessible to More PatientsBoston Scientific Corporation (NYSE: BSX) today announced that it has received the European CE Mark for its new Artisan™ 2x8 Surgical Lead for use... 
- 
Nov 2, 2006Boston Scientific Corporation (NYSE: BSX) today announced that Daniel J. Brennan has been appointed to the position of Vice President Investor...